Fundraising FoxCommense Bio
Boulder, US · Delaware corporation
Find your way into Commense Bio
Sign up to see every warm intro you have to Commense Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Commense Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Commense Bio develops bacterial biotherapeutics using genetically engineered bacteria to treat patients with invasive infectious diseases. It operates in the biotech sector focused on next-generation therapeutics for multiple infectious diseases.
Founders & leadership
TT
Todd TurnerFounder2015–2023Todd Turner is a physician with experience in clinical research and hospital administration, including work with biopharma startups. He serves as Executive Officer and Director at Commense Bio, which develops genetically engineered bacterial therapeutics for infectious diseases.
Board
RW
Randall W. ViolaBoard director
EP
Erik PrenticeBoard director
JS
Joshua SmithBoard director
JB
Judith BoiceBoard director
NS
N. Stuart HarrisBoard director
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 1 round · 2026
▶$2.5MraisedJun 2026 · 31 investors · BiotechnologyRule 506(b)
▶$2.5MraisedJun 2026 · 31 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Todd TurnerExecutive Officer, Director
- Randall W. ViolaDirector
- Erik PrenticeDirector
- Joshua SmithDirector
- Judith BoiceDirector
- N. Stuart HarrisDirector
- Offering amount
- $2.7M
- Amount sold
- $2.5M
- First sale
- Jan 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Commense Bio do?
- Commense Bio develops bacterial biotherapeutics using genetically engineered bacteria to treat patients with invasive infectious diseases. It operates in the biotech sector focused on next-generation therapeutics for multiple infectious diseases.
- How much funding has Commense Bio raised?
- Commense Bio has disclosed $2.5M raised across 1 round.
- Where is Commense Bio headquartered?
- Commense Bio is headquartered in Boulder, US.